Promaxo Announces Participation at the Oppenheimer 32nd Annual Healthcare Conference

Promaxo, Inc. (“Promaxo” or the “Company”), a medical imaging, robotics, and AI technology company, today announced Amit Vohra, PhD, President and Chief Executive Officer, will participate at the Oppenheimer 32^nd Annual Healthcare Conference.

Promaxo will give a virtual corporate presentation on Tuesday, March 15, 2022 at 4:40pm ET and host investor 1x1 meetings, which can be requested through Oppenheimer.

About Promaxo, Inc.
Promaxo was founded by a team of entrepreneurs and healthcare innovators to develop a minimally-invasive and patient-centric MRI and robotic platform. Based in Oakland, California, and backed by over 200 patents, the Company’s mission is to improve lives through state-of-the-art medical imaging, robotics and AI capabilities. With a compact and adaptable MRI, Promaxo is redefining the standard of care by improving the quality and speed of patient diagnosis and interventions. The Company has formed numerous long-term and strategic partnerships with investor groups and corporation as it drives commercialization of the Promaxo MRI system.